Proactive Investors - Run By Investors For Investors

Marin Software shares slide on disappointing 4Q results

In its latest quarter, the San Francisco company reported a loss of $2.8 million
cloud computing
Marin sells enterprise marketing software to advertisers

Shares of Marin Software Inc (NASDAQ:MRIN) tumbled in pre-market trade Friday, after the cloud-centered digital marketing software group disappointed investors by posting a loss of $2.8 million in the fourth quarter.

In its latest quarter, the San Francisco company reported a loss of $0.48 per share and a loss of $0.06 per share on an adjusted basis.

Its sales also fell to $15.8 million, from $17.7 million in the fourth quarter of 2017.

Boost to company in 2019​

In response, Marin shares slid 28.8% to $4.70 before the opening bell.

In a statement, Marin CEO Chris Lien said the company's recent revenue-share agreement with Google and support for additional channels such as YouTube will boost the company's fortunes in 2019.

"All of our customers now have access to our latest technology to help them deliver performance from their Search, Social and eCommerce advertising," Lien said. "Support for additional channels like Apple Search Ads and YouTube, along with our recently announced revenue share agreement with Google, will help us drive growth for our customers in 2019."

For the full year, Marin saw losses widen to $41.67 million, or $7.21 per share on revenue of $58.6 million.

Looking ahead to the current quarter ending March 31, Marin expects revenues to fall between $12.3m and $12.8 million and its non-GAAP loss from operations to stay in the range of $3.7 million to $4.2 million.

Marin sells enterprise marketing software to advertisers.

Contact Ellen Kelleher at [email protected]

View full MRIN profile View Profile

Marin Software Inc Timeline

Related Articles

computing symbols in cyberspace
January 15 2019
Its team of computer scientists designs algorithms that will be used by high-frequency traders, scientists doing genetic research and pharmaceutical companies
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use